Department of Medicine, James J. Peters VA Medical Center, Bronx, NY, USA.
Department of Biology, University of Alabama at Birmingham, Birmingham, AL, USA.
J Vasc Access. 2023 Jan;24(1):107-116. doi: 10.1177/11297298211015069. Epub 2021 May 17.
Vascular access is the Achilles' heel of dialysis therapy among patient with end stage kidney disease. The development of neointimal hyperplasia and subsequent stenosis is common in vascular access and is associated with significant morbidity. Percutaneous transluminal angioplasty using balloon inflation was the standard therapy of these lesions. However, the balloon-based approaches were associated with poor vascular access patency rate necessitating new inventions. It is within this context that different types of stents were developed in order to improve the overall dialysis vascular access functionality. In this article, we review the available literature regarding the use of stents in treating dialysis vascular access stenotic lesions. Further, we review the major clinical trials of stent use in different anatomic locations and in different clinical scenarios.
血管通路是终末期肾病患者透析治疗的阿喀琉斯之踵。新生内膜增生和随后的狭窄在血管通路中很常见,并且与显著的发病率相关。球囊扩张经皮腔内血管成形术是这些病变的标准治疗方法。然而,基于球囊的方法与较差的血管通路通畅率相关,需要新的发明。正是在这种情况下,为了提高整体透析血管通路功能,开发了不同类型的支架。在本文中,我们回顾了关于支架在治疗透析血管通路狭窄病变中的应用的现有文献。此外,我们还回顾了支架在不同解剖部位和不同临床情况下使用的主要临床试验。